110 related articles for article (PubMed ID: 6892700)
1. Properties of a cell-culture line derived from lymphosarcoma P1798.
Thompson EA
Mol Cell Endocrinol; 1980 Feb; 17(2):95-102. PubMed ID: 6892700
[TBL] [Abstract][Full Text] [Related]
2. Biochemical and molecular characterization of the glucocorticoid receptor of lymphosarcoma P1798 variants.
Lucas KL; Barbour KW; Housley PR; Thompson EA
Mol Endocrinol; 1988 Mar; 2(3):291-9. PubMed ID: 3398856
[TBL] [Abstract][Full Text] [Related]
3. Hormonal regulation of transcription of rDNA. Inhibition of transcription during glucocorticoid-mediated inhibition of proliferation of lymphosarcoma P1798 cells in culture.
Cavannaugh AH; Thompson EA
J Biol Chem; 1983 Aug; 258(16):9768-73. PubMed ID: 6688417
[TBL] [Abstract][Full Text] [Related]
4. Nuclear binding of steroid-receptor complex to lymphosarcoma P1798 resistant and sensitive cells and effect of concanavalin A on receptor levels.
McPartland RP; Milholland RJ; Rosen F
Cancer Res; 1977 Dec; 37(12):4256-60. PubMed ID: 579163
[TBL] [Abstract][Full Text] [Related]
5. Nonmutational alteration in glucocorticoid sensitivity of lymphosarcoma P1798.
Davis JM; Chan AK; Thompson EA
J Natl Cancer Inst; 1980 Jan; 64(1):55-62. PubMed ID: 6928047
[TBL] [Abstract][Full Text] [Related]
6. Isolation and characterization of cortisol-sensitive and -resistant P1798 mouse lymphosarcoma cell lines.
Chi CW; Sykes D; Ip MM
Mol Cell Endocrinol; 1989 Apr; 62(2):167-76. PubMed ID: 2744225
[TBL] [Abstract][Full Text] [Related]
7. Glucocorticoid effects of lymphosarcoma P1798 on DNA replication and growth of subcutaneous tumors in mice.
Thompson EA; Moore WM; Sawyer RH
J Natl Cancer Inst; 1980 Aug; 65(2):477-83. PubMed ID: 6931263
[TBL] [Abstract][Full Text] [Related]
8. Physicochemical differences between glucocorticoid-binding components from the corticoid-sensitive and -resistant strains of mouse lymphoma P1798.
Stevens J; Stevens YW
Cancer Res; 1979 Oct; 39(10):4011-21. PubMed ID: 476639
[TBL] [Abstract][Full Text] [Related]
9. Glucocorticoid inhibition of initiation of transcription of the DNA encoding rRNA (rDNA) in lymphosarcoma P1798 cells.
Cavanaugh AH; Gokal PK; Lawther RP; Thompson EA
Proc Natl Acad Sci U S A; 1984 Feb; 81(3):718-21. PubMed ID: 6322167
[TBL] [Abstract][Full Text] [Related]
10. Isolation and characterization of lymphosarcoma P1798 variants selected for resistance to the cytolytic effects of glucocorticoids in vivo and in culture.
Wood KM; Thompson EA
Mol Cell Endocrinol; 1984 Sep; 37(2):169-80. PubMed ID: 6092172
[TBL] [Abstract][Full Text] [Related]
11. Insensitivity to the cytolytic effects of glucocorticoids in vivo is associated with a novel "slow death" phenotype.
Thompson EA
Cancer Res; 1991 Oct; 51(20):5544-50. PubMed ID: 1913673
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of glucose uptake in lymphosarcoma P1798 by cortisol and its relationship to the biosynthesis of deoxyribonucleic acid.
Rosen JM; Fina JR; Milholland J; Rosen F
J Biol Chem; 1970 Apr; 245(8):2074-80. PubMed ID: 5467455
[No Abstract] [Full Text] [Related]
13. Inhibitory and stimulatory effects of glucocorticoid on androgen-induced growth of murine Shionogi carcinoma 115 in vivo and in cell culture.
Hiraoka D; Nakamura N; Nishizawa Y; Uchida N; Noguchi S; Matsumoto K; Sato B
Cancer Res; 1987 Dec; 47(24 Pt 1):6560-4. PubMed ID: 3677094
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of thymidine and basic amino acid metabolism in P1798 lymphosarcoma by L-asparaginase.
Mashburn LT; Landin LM
Cancer Res; 1974 Feb; 34(2):313-8. PubMed ID: 4589953
[No Abstract] [Full Text] [Related]
15. Cell membrane sialoglycopeptides of corticoid-sensitive and -resistant lymphosarcoma P1798.
Behrens UJ; Hollander VP
Cancer Res; 1976 Jan; 36(1):172-80. PubMed ID: 946164
[TBL] [Abstract][Full Text] [Related]
16. Glucocorticoid-induced growth inhibition of human neoplastic salivary gland duct cell line (HSG).
Hatakeyama S; Kurokawa R; Satoh M; Suzuki A; Ota M; Shirasuna K
Acta Pathol Jpn; 1987 Apr; 37(4):587-95. PubMed ID: 3618224
[TBL] [Abstract][Full Text] [Related]
17. Glucocorticoid binding properties of mouse thymic lymphosarcoma cell populations selected for resistance to the cytolytic effects of glucocorticoids in vivo.
Chan AK; Thompson EA
J Natl Cancer Inst; 1983 Sep; 71(3):579-82. PubMed ID: 6577232
[TBL] [Abstract][Full Text] [Related]
18. Kinetics of adenosine 3':5'-monophosphate-dependent protein kinase activation and inhibition of thymidine incorporation into DNA in P1798 lymphosarcoma cells.
Michnoff CA; de la Houssaye BA; Masaracchia RA
Cancer Res; 1983 Aug; 43(8):3514-20. PubMed ID: 6305487
[TBL] [Abstract][Full Text] [Related]
19. Glucocorticoid receptors and mechanism of resistance in the cortisol-sensitive and -resistant lines of lymphosarcoma P1798.
Kaiser N; Milholland RJ; Rosen F
Cancer Res; 1974 Mar; 34(3):621-6. PubMed ID: 4359883
[No Abstract] [Full Text] [Related]
20. Lymphoma cell variants of decreased glucocorticoid sensitivity.
Gehring U; Ulrich J; Segnitz B
Mol Cell Endocrinol; 1982; 28(3):605-11. PubMed ID: 7152096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
